drug costs

Employer Group Launches Its Own PBM
Human Capital

Employer Group Launches Its Own PBM

EmsanaRx aims to address “the lack of accountability of the PBM industry to its employer clients."
By Matthew Heller | October 25, 2021
Read More
Specialty Drug Costs to Soar Again in 2018
Human Capital & Careers

Specialty Drug Costs to Soar Again in 2018

The rate of spending increase on high-tech pharmaceuticals will top 17% for a second consecutive year, a study says.
By David McCann | September 22, 2017
Read More
How to Rein In the Soaring Costs of Specialty Drugs
Risk & Compliance

How to Rein In the Soaring Costs of Specialty Drugs

The 420-employer National Business Group on Health recommends public-policy changes relating to the proliferating category of specialty drugs.
By David McCann | January 30, 2017
Read More
Specialty Drugs Drive Health Care Cost Trend
Human Capital & Careers

Specialty Drugs Drive Health Care Cost Trend

Health benefits costs are forecast to climb 5% next year, thanks in part to fast-rising prices for specialty pharmaceuticals.
By David McCann | August 9, 2016
Read More
Walgreens Buys Rite Aid for $9.4 Billion
Strategy

Walgreens Buys Rite Aid for $9.4 Billion

The combination of two of the three largest U.S. drug store chains continues a wave of industry consolidation spurred by the Affordable Care Act.
By Katie Kuehner-Hebert | October 28, 2015
Read More
Specialty Drugs Eat More of Health-Care Spending Pie
Human Capital & Careers

Specialty Drugs Eat More of Health-Care Spending Pie

Thanks to a proliferation of high-cost drugs for complex conditions, pharmacy expenses outpace overall medical cost growth.
By David McCann | February 25, 2015
Read More
Drug Prices: Costly Cures
Risk & Compliance

Drug Prices: Costly Cures

An American fight over expensive new treatments has global implications.
By Economist Staff | June 9, 2014
Read More